High value-added solutions for strategic markets
DEVELOPMENT OF ELECTROSPINNING TECHNOLOGY FOR INNOVATIONS IN THE COSMETICS AND MEDICAL SECTORS
SPIN2CARE
Motivation
SPIN2CARE responds to the growing need for innovation in the medical and cosmetic sectors by developing solutions based on functionalized nanofibers obtained by electrospinning technology. These sectors present significant challenges related to the efficacy, safety and sustainability of products, especially in frontier applications combining personal care, prevention and treatment of damaged tissue.
In addition, the project builds on the experience of AITEX in the development of functionalized nanofiber veils, such as in the REPAIR project, which validated the use of electrospinning for wound regeneration in patients with severe burns. SPIN2CARE seeks to advance the optimization of these nanofibers for medical and cosmetic applications, overcoming regulatory and technical barriers and setting standards for technology transfer from the laboratory to industrial production.
Objectives
The main objective is to promote research and production of solutions based on nanofibers to impact on people’s quality of life. An additional aim is to study frontier products in the medical and cosmetic sectors; in particular, those formed by nanofibers with functional substances, used in the care, prevention, treatment and relief of damaged tissue. A third objective is to evaluate the regulatory framework and the standardization of processes for the industrialization of electrospinning technology in these sectors.
Value and competitive advantage
-
Positions electrospinning technology as a differentiating solution for high‑value medical and cosmetic products.
-
Enables the development of borderline products supported by scientific evidence and early regulatory feasibility.
-
Provides controlled release of active substances, enhancing efficacy and safety compared to conventional formats.
Obtained results
-
Development of nanofiber veils by electrospinning, functionalized with active substances for medical and cosmetic applications.
-
Functionalization of DL‑PLGA nanofibers with antibiotics, achieving controlled release and high antibacterial activity.
-
Validation of biocompatibility, microbiological safety and antibacterial efficacy according to healthcare reference standards.
-
Development of nanofiber veils for cosmetic applications using different polymers and application‑specific formats.
-
Mechanical, morphological and functional characterization of nanofibers to define design criteria according to end use.
-
Demonstration of industrial scalability through needle‑free electrospinning and the use of lower‑impact solvents.
-
Definition of the regulatory framework and roadmap for transfer to medical devices and cosmetic products.
Grant number: PENDING
Programme: Plan of non-economic activities 2025
Period of execution: January 2025 – December 2025
Status: Finished
More information: PLAN OF ACTION
Entity: IVACE
Project supported by the Ministry of Innovation, Industry, Commerce and Tourism of the Generalitat Valenciana, through IVACE.
CONTACT US
Do you want to contact us? Click on the button and write to us.
R&D AREAS
New high-performance functionalised materials
Circular economy and sustainability
Advanced manufacturing, smart textiles and digitalisation
High value-added solutions for strategic markets
RELATED PROJECTS
NEWS
AITEX is present at the Babykid FIMI fair at Feria Valencia from January 26 to 28, presenting tests and certifications for children’s products.
AITEX has attended the Cosmetorium fair in Barcelona once again on October to present its new products for the cosmetic sector.
AITEX has hosted the LIFE POLITEX workshop entitled “Closing the textile polyester cycle: challenges and opportunities”, based on promoting sustainable solutions for the management and recycling of textile materials.